These aren't the glory days for med-tech giant Medtronic (NYSE: MDT ), as fiscal 2014 will be a pretty weak year from a growth perspec...
These aren't the glory days for med-tech giant Medtronic (NYSE: MDT ), as fiscal 2014 will be a pretty weak year from a growth perspec...